These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12694059)

  • 1. Allograft rejection in a new allospecific CD4+ TCR transgenic mouse.
    Sayegh MH; Wu Z; Hancock WW; Langmuir PB; Mata M; Sandner S; Kishimoto K; Sho M; Palmer E; Mitchell RN; Turka LA
    Am J Transplant; 2003 Apr; 3(4):381-9. PubMed ID: 12694059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloreactive T cell responses and acute rejection of single class II MHC-disparate heart allografts are under strict regulation by CD4+ CD25+ T cells.
    Schenk S; Kish DD; He C; El-Sawy T; Chiffoleau E; Chen C; Wu Z; Sandner S; Gorbachev AV; Fukamachi K; Heeger PS; Sayegh MH; Turka LA; Fairchild RL
    J Immunol; 2005 Mar; 174(6):3741-8. PubMed ID: 15749914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of myeloid related protein-8/14 exacerbates cardiac allograft rejection.
    Shimizu K; Libby P; Rocha VZ; Folco EJ; Shubiki R; Grabie N; Jang S; Lichtman AH; Shimizu A; Hogg N; Simon DI; Mitchell RN; Croce K
    Circulation; 2011 Dec; 124(25):2920-32. PubMed ID: 22144572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical influence of natural regulatory CD25+ T cells on the fate of allografts in the absence of immunosuppression.
    Benghiat FS; Graca L; Braun MY; Detienne S; Moore F; Buonocore S; Flamand V; Waldmann H; Goldman M; Le Moine A
    Transplantation; 2005 Mar; 79(6):648-54. PubMed ID: 15785370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for cooperativity in the rejection of cardiac grafts mediated by CD4 TCR Tg T cells specific for a defined allopeptide.
    Honjo K; Yan Xu X; Kapp JA; Bucy RP
    Am J Transplant; 2004 Nov; 4(11):1762-8. PubMed ID: 15476474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4(+) T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Mar; 81(5):726-35. PubMed ID: 16534475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft.
    Buonocore S; Flamand V; Goldman M; Braun MY
    Transplantation; 2003 Feb; 75(3):407-13. PubMed ID: 12589166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new T-cell receptor transgenic model of the CD4+ direct pathway: level of priming determines acute versus chronic rejection.
    Brennan TV; Hoang V; Garrod KR; Liu FC; Hayden T; Kim J; Kang SM
    Transplantation; 2008 Jan; 85(2):247-55. PubMed ID: 18212630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4 T cell-mediated rejection of cardiac allografts in B cell-deficient mice.
    Nozaki T; Rosenblum JM; Ishii D; Tanabe K; Fairchild RL
    J Immunol; 2008 Oct; 181(8):5257-63. PubMed ID: 18832680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monokine induced by interferon-gamma (MIG/CXCL9) is derived from both donor and recipient sources during rejection of class II major histocompatibility complex disparate skin allografts.
    Auerbach MB; Shimoda N; Amano H; Rosenblum JM; Kish DD; Farber JM; Fairchild RL
    Am J Pathol; 2009 Jun; 174(6):2172-81. PubMed ID: 19389928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
    Tomita Y; Mayumi H; Eto M; Nomoto K
    J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy.
    Yang J; Popoola J; Khandwala S; Vadivel N; Vanguri V; Yuan X; Dada S; Guleria I; Tian C; Ansari MJ; Shin T; Yagita H; Azuma M; Sayegh MH; Chandraker A
    Circulation; 2008 Feb; 117(5):660-9. PubMed ID: 18212277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
    Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
    Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel CD8 T cell alloreactivities in CCR5-deficient recipients of class II MHC disparate kidney grafts.
    Ishii D; Rosenblum JM; Nozaki T; Schenk AD; Setoguchi K; Su CA; Gorbacheva V; Baldwin WM; Valujskikh A; Fairchild RL
    J Immunol; 2014 Oct; 193(7):3816-24. PubMed ID: 25172484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of autoimmunity after skin graft rejection via an indirect alloresponse.
    Valujskikh A; Fedoseyeva E; Benichou G; Heeger PS
    Transplantation; 2002 Apr; 73(7):1130-7. PubMed ID: 11965045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCR5 is required for regulation of alloreactive T-cell responses to single class II MHC-mismatched murine cardiac grafts.
    Nozaki T; Rosenblum JM; Schenk AD; Ishii D; Fairchild RL
    Am J Transplant; 2009 Oct; 9(10):2251-61. PubMed ID: 19656127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TIM-3: a novel regulatory molecule of alloimmune activation.
    Boenisch O; D'Addio F; Watanabe T; Elyaman W; Magee CN; Yeung MY; Padera RF; Rodig SJ; Murayama T; Tanaka K; Yuan X; Ueno T; Jurisch A; Mfarrej B; Akiba H; Yagita H; Najafian N
    J Immunol; 2010 Nov; 185(10):5806-19. PubMed ID: 20956339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adoptive transfer of a Th2-like cell line prolongs MHC class II antigen disparate skin allograft survival in the mouse.
    Maeda H; Takata M; Takahashi S; Ogoshi S; Fujimoto S
    Int Immunol; 1994 Jun; 6(6):855-62. PubMed ID: 8086373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-cell interaction in graft rejection responses: induction of anti-allo-class I H-2 tolerance is prevented by immune responses against allo-class II H-2 antigens coexpressed on tolerogen.
    Hori S; Kitagawa S; Iwata H; Ochiai T; Isono K; Hamaoka T; Fujiwara H
    J Exp Med; 1992 Jan; 175(1):99-109. PubMed ID: 1730930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.